Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation
BLOOD CANCER JOURNAL(2022)
Key words
Chronic myeloid leukaemia,Genetics research,Innate immunity,Risk factors,Biomedicine,general,Cancer Research,Oncology,Hematology
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined